NEW YORK, Jan. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
MediPoint: Renal Denervation - Current and Future Players
MediPoint: Renal Denervation - Current and Future Players
Summary
Numerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions worldwide, with some studies estimating that 50% of the adult population globally will have the disease in the next 20 years. With limited effectiveness from pharmacotherapy, medical device therapy has the potential for significant adoption in the treatment of resistive hypertension and uncontrolled hypertension, once efficacy and cost-effectiveness are proven. Additionally, the degree of blood pressure reduction found in long-term clinical trials from such a well-tolerated procedure has generated notable optimism about the intervention's application in other conditions where hyperactivity of the sympathetic nervous system plays a significant role, such as congestive heart failure.
The report identifies and analyzes the key companies shaping and driving the global renal denervation market. The report provides insight into the competitive renal denervation landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by GlobalData's team of industry experts.
Scope
- Investigation of current and future market competition for renal denervation
- Competitor assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using renal denervation devices in clinical practice.
Reasons to buy
- Gain a high level view of the trends shaping and driving the renal denervation market for coronary applications and peripheral applications in the lower extremity.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 10
2 Introduction 12
2.1 Overview 12
2.2 Catalyst 13
3 Marketed Products 14
3.1 Overview 14
3.2 Market Share 16
3.2.1 US Market Share, 2013 and 2016 16
3.2.2 France Market Share, 2013 and 2016 17
3.2.3 Germany Market Share, 2013 and 2016 19
3.2.4 Italy Market Share, 2013 and 2016 21
3.2.5 Spain Market Share, 2013 and 2016 23
3.2.6 UK Market Share, 2013 and 2016 25
3.2.7 Japan Market Share, 2013 and 2016 27
3.2.8 Brazil Market Share, 2013 and 2016 28
3.2.9 India Market Share, 2013 and 2016 29
3.2.10 China Market Share, 2013 and 2016 30
3.3 Allegra Renal Denervation System (Terumo/AngioCare) 31
3.3.1 Overview 31
3.3.2 Safety and Efficacy 32
3.3.3 SWOT Analysis 33
3.4 EnligHTN Renal Denervation System (St. Jude Medical) 34
3.4.1 Overview 34
3.4.2 Safety and Efficacy 35
3.4.3 SWOT Analysis 37
3.5 OneShot Renal Denervation System (Covidien) 38
3.5.1 Overview 38
3.5.2 Safety and Efficacy 39
3.5.3 SWOT Analysis 40
3.6 Paradise Renal Denervation System (ReCor Medical) 41
3.6.1 Overview 41
3.6.2 Safety and Efficacy 42
3.6.3 SWOT Analysis 43
3.7 Symplicity Renal Denervation System (Medtronic) 44
3.7.1 Overview 44
3.7.2 Safety and Efficacy 46
3.7.3 SWOT Analysis 49
3.8 Vessix Renal Denervation System (Boston Scientific Corporation) 50
3.8.1 Overview 50
3.8.2 Safety and Efficacy 51
3.8.3 SWOT Analysis 52
4 Pipeline Products 53
4.1 Overview 53
4.2 Beta-Cath System (Best Medical International) 53
4.2.1 Overview 53
4.2.2 Safety and Efficacy 53
4.2.3 SWOT Analysis 54
4.3 Bullfrog MicroFusion Catheter (Mercator MedSystems) 55
4.3.1 Overview 55
4.3.2 Safety and Efficacy 56
4.3.3 SWOT Analysis 56
4.4 Chemical Denervation System (Kipprokration Hospital) 57
4.4.1 Overview 57
4.4.2 Safety and Efficacy 57
4.4.3 SWOT Analysis 58
4.5 Cryoablation System (Cryomend) 59
4.5.1 Overview 59
4.5.2 Safety and Efficacy 59
4.5.3 SWOT Analysis 60
4.6 Kona Surround Sound System (Kona Medical) 61
4.6.1 Overview 61
4.6.2 Safety and Efficacy 62
4.6.3 SWOT Analysis 63
4.7 Magnetic Nanoparticles (ApexNano) 64
4.7.1 Overview 64
4.7.2 Safety and Efficacy 64
4.7.3 SWOT Analysis 65
4.8 Perivascular Renal Denervation System (Ablative Solutions) 66
4.8.1 Overview 66
4.8.2 Safety and Efficacy 66
4.8.3 SWOT Analysis 67
4.9 Sound 360 Ultrasonic Renal Denervation System (Sound Interventions) 68
4.9.1 Overview 68
4.9.2 Safety and Efficacy 69
4.9.3 SWOT Analysis 70
4.10 Symple Surgical System (Symple Surgical) 71
4.10.1 Overview 71
4.10.2 Safety and Efficacy 71
4.10.3 SWOT Analysis 71
4.11 Tivus System (Cardiosonic) 72
4.11.1 Overview 72
4.11.2 Safety and Efficacy 73
4.11.3 SWOT Analysis 74
4.12 Celsius ThermoCool System (Cordis/Johnson & Johnson) 75
4.12.1 Overview 75
4.12.2 Safety and Efficacy 75
4.12.3 SWOT Analysis 76
4.13 Northwind Medical System (Northwind Medical) 77
4.13.1 Overview 77
4.13.2 Safety and Efficacy 77
4.13.3 SWOT Analysis 77
4.14 Verve Medical System (Verve Medical) 78
4.14.1 Overview 78
4.14.2 Safety and Efficacy 78
4.14.3 SWOT Analysis 79
5 Current and Future Players 80
5.1 Trends in Corporate Strategy 80
5.2 Company Profiles 81
5.2.1 Ablative Solutions 81
5.2.2 ApexNano 84
5.2.3 Best Medical International 87
5.2.4 Boston Scientific Corporation 89
5.2.5 Cardiosonic 92
5.2.6 Covidien 95
5.2.7 Cordis Corporation and Johnson & Johnson 98
5.2.8 Cryomend 101
5.2.9 Kona Medical 103
5.2.10 Medtronic 106
5.2.11 Mercator MedSystems 109
5.2.12 Northwind Medical 112
5.2.13 ReCor Medical 114
5.2.14 Sound Interventions 117
5.2.15 St. Jude Medical 120
5.2.16 Symple Surgical 123
5.2.17 Terumo Corporation 125
5.2.18 Verve Medical 128
6 Appendix 131
6.1 Bibliography 131
6.2 Abbreviations 138
6.3 Report Methodology 141
6.3.1 Overview 141
6.3.2 Coverage 141
6.3.3 Primary Research 142
6.3.4 Secondary Research 143
6.3.5 Forecasting Methodology 143
6.4 Key Opinion Leaders Included in this Study 144
6.5 About the Authors 145
6.5.1 Joseph A. Gregory, Analyst, Surgical Devices 145
6.5.2 Derek Archila, MBA, Director of Research and Analysis, Medical Devices 145
6.6 Global Head of Healthcare 146
6.6.1 Bonnie Bain, Ph.D., Global Head of Healthcare 146
6.7 About MediPoint 147
6.8 About GlobalData 147
6.9 Disclaimer 147
List of Tables
Table 1: Classification of the Marketed Renal Denervation Systems 14
Table 2: Product Profile - Allegra Renal Denervation System 32
Table 3: Allegra Renal Denervation System - SWOT Analysis, 2013 33
Table 4: Product Profile - EnligHTN Renal Denervation System 35
Table 5: EnligHTN Renal Denervation System - SWOT Analysis, 2013 37
Table 6: Product Profile - OneShot Renal Denervation System 39
Table 7: OneShot System - SWOT Analysis, 2013 40
Table 8: Product Profile - Paradise Renal Denervation System 42
Table 9: Paradise Renal Denervation System - SWOT Analysis, 2013 43
Table 10: Product Profile - Symplicity Renal Denervation System 45
Table 11: Efficacy Results of the Symplicity HTN-1 Clinical Trial 46
Table 12: Efficacy Results of the Symplicity HTN-2 Clinical Trial 47
Table 13: Symplicity Renal Denervation System - SWOT Analysis, 2013 49
Table 14: Product Portfolio - Vessix Renal Denervation System 51
Table 15: Vessix Renal Denervation System - SWOT Analysis, 2013 52
Table 16: Beta-Cath System - SWOT Analysis, 2013 54
Table 17: Bullfrog MicroFusion Catheter - SWOT Analysis, 2013 56
Table 18: Chemical Denervation System - SWOT Analysis, 2013 58
Table 19: Cryoablation System - SWOT Analysis, 2013 60
Table 20: Surround Sound Renal Denervation System - SWOT Analysis, 2013 63
Table 21: Magnetic Nanoparticles System - SWOT Analysis, 2013 65
Table 22: Perivascular Renal Denervation System - SWOT Analysis, 2013 67
Table 23: Sound 360 Ultrasonic Renal Denervation System - SWOT Analysis, 2013 70
Table 24: Symple Surgical Renal Denervation System - SWOT Analysis, 2013 71
Table 25: Tivus Renal Denervation System - SWOT Analysis, 2013 74
Table 26: Celsius Thermocool Renal Denervation System - SWOT Analysis, 2013 76
Table 27: Northwind Medical Renal Denervation System - SWOT Analysis, 2013 77
Table 28: Verve Medical Renal Denervation System - SWOT Analysis, 2013 79
Table 29: Company Profile - Ablative Solutions 81
Table 30: Ablative Solutions - SWOT Analysis, 2013 83
Table 31: Company Profile - ApexNano 84
Table 32: ApexNano - SWOT Analysis, 2013 86
Table 33: Company Profile - Best Medical International 87
Table 34: Best Medical International - SWOT Analysis, 2013 88
Table 35: Company Profile - Boston Scientific Corporation 89
Table 36: Boston Scientific - SWOT Analysis, 2013 91
Table 37: Company Profile - Cardiosonic 92
Table 38: CardioSonic - SWOT Analysis, 2013 94
Table 39: Company Profile - Covidien 95
Table 40: Covidien - SWOT Analysis, 2013 97
Table 41: Company Profile - Cordis Corporation 98
Table 42: Cordis Corporation - SWOT Analysis, 2013 100
Table 43: Company Profile - Cryomend 101
Table 44: Cryomend - SWOT Analysis, 2013 102
Table 45: Company Profile - Kona Medical 103
Table 46: Kona Medical - SWOT Analysis, 2013 105
Table 47: Company Profile - Medtronic 106
Table 48: Medtronic - SWOT Analysis, 2013 108
Table 49: Company Profile - Mercator MedSystems 109
Table 50: Mercator Medsystems - SWOT Analysis, 2013 111
Table 51: Company Profile - Northwind Medical 112
Table 52: Northwind Medical - SWOT Analysis, 2013 113
Table 53: Company Profile - Recor Medical 114
Table 54: ReCor Medical - SWOT Analysis, 2013 116
Table 55: Company Profile - Sound Interventions 117
Table 56: Sound Interventions - SWOT Analysis, 2013 119
Table 57: Company Portfolio - St. Jude Medical 120
Table 58: St. Jude Medical - SWOT Analysis, 2013 122
Table 59: Company Portfolio - Symple Surgical 123
Table 60: Symple Surgical - SWOT Analysis, 2013 124
Table 61: Company Profile - Terumo Corporation 125
Table 62: Terumo Corporation - SWOT Analysis, 2013 127
Table 63: Company Portfolio - Verve Medical 128
Table 64: Verve Medical - SWOT Analysis, 2013 130
List of Figures
Figure 1: United States Renal Denervation Market Share, 2016 16
Figure 2: France Renal Denervation Market Share, 2013 18
Figure 3: France Renal Denervation Market Share, 2016 18
Figure 4: Germany Renal Denervation Market Share, 2013 19
Figure 5: Germany Renal Denervation Market Share, 2016 20
Figure 6: Italy Renal Denervation Market Share, 2013 21
Figure 7: Italy Renal Denervation Market Share, 2016 22
Figure 8: Spain Renal Denervation Market Share, 2013 23
Figure 9: Spain Renal Denervation Market Share, 2016 24
Figure 10: United Kingdom Renal Denervation Market Share, 2013 25
Figure 11: United Kingdom Renal Denervation Market Share, 2016 26
Figure 12: Japan Renal Denervation Market Share, 2016 27
Figure 13: Brazil Renal Denervation Market Share, 2016 28
Figure 14: India Renal Denervation Market Share, 2016 29
Figure 15: China Renal Denervation Market Share, 2016 30
Figure 16: Allegra Renal Denervation System 31
Figure 17: EnligHTN Renal Denervation System 34
Figure 18: OneShot Renal Denervation System Balloon Catheter 38
Figure 19: Paradise Renal Denervation System 41
Figure 20: Symplicity Renal Denervation System 44
Figure 21: Vessix Renal Denervation System Catheter 50
Figure 22: Bullfrog MicroFusion Catheter 55
Figure 23: Chemical Denervation System 57
Figure 24: Kona Surround Sound Renal Denervation System 61
Figure 25: Sound 360 Ultrasonic Renal Denervation System 68
Figure 26: Tivus Renal Denervation System 72
Figure 27: Tivus Renal Denervation System Catheter 73
Companies Mentioned
Ablative Solutions
ApexNano
Best Medical International
Boston Scientific Corporation
Cardiosonic
Covidien
Cordis Corporation and Johnson & Johnson
Cryomend
Kona Medical
Medtronic
Mercator MedSystems
Northwind Medical
ReCor Medical
Sound Interventions
St. Jude Medical
Symple Surgical
Terumo Corporation
Verve Medical
To order this report: MediPoint: Renal Denervation - Current and Future Players
http://www.reportlinker.com/p01921136/MediPoint-Renal-Denervation---Current-and-Future-Players.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Healthcare
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article